PremiumThe FlyWindtree Therapeutics announces presentation highlighting istaroxime Windtree receives advice from IP, FDA on exclusivity strategy for istaroxime Windtree Therapeutics enters Assignment, Conditional Assumption Agreement PremiumCompany AnnouncementsWindtree Therapeutics Delays Annual Report Filing Windtree Therapeutics Inc (WINT) Q4 Earnings Cheat Sheet Evofem announces license and supply agreement with Windtree Therapeutics PremiumThe FlyWindtree Therapeutics Inc trading halted, news pending Windtree Therapeutics Announces Reverse Stock Split Approval Windtree Therapeutics board approves 1-for-50 reverse stock split